0001437749-23-026076.txt : 20230915
0001437749-23-026076.hdr.sgml : 20230915
20230915185437
ACCESSION NUMBER: 0001437749-23-026076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230915
FILED AS OF DATE: 20230915
DATE AS OF CHANGE: 20230915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALAM JOHN J
CENTRAL INDEX KEY: 0001197014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37942
FILM NUMBER: 231259830
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CervoMed Inc.
CENTRAL INDEX KEY: 0001053691
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300645032
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02216
BUSINESS PHONE: (617) 744-4400
MAIL ADDRESS:
STREET 1: 20 PARK PLAZA
STREET 2: SUITE 424
CITY: BOSTON
STATE: MA
ZIP: 02216
FORMER COMPANY:
FORMER CONFORMED NAME: Diffusion Pharmaceuticals Inc.
DATE OF NAME CHANGE: 20160115
FORMER COMPANY:
FORMER CONFORMED NAME: RestorGenex Corp
DATE OF NAME CHANGE: 20140307
FORMER COMPANY:
FORMER CONFORMED NAME: Stratus Media Group, Inc
DATE OF NAME CHANGE: 20080722
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-09-15
0001053691
CervoMed Inc.
CRVO
0001197014
ALAM JOHN J
20 PARK PLAZA, SUITE 424
BOSTON
MA
02116
1
1
1
CEO & President
0
Stock Option (Right to Buy)
5.33
2023-09-15
4
A
0
35500
0
A
2033-09-15
Common Stock
35500
35500
D
Stock Option (Right to Buy)
5.33
2023-09-15
4
A
0
6450
0
A
2033-09-15
Common Stock
6450
6450
I
By Spouse
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023.
Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ William R. Elder, attorney-in-fact for the Reporting Person
2023-09-15